PURPLE BIOTECH LTD.
Income Statement
| Line Item | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|
| Revenue | $1.0M | $1.0M | $1.0M | $100.0K |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $6.0M | $4.4M | — | — |
| Operating Income | $-12.6M | $-7.2M | $-7.8M | $-12.0M |
| Operating Margin | -1,261.2% | -715.6% | -782.6% | -11,966.0% |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | $216.0K | — | — |
| Net Income | $28.7M | $5.4M | $5.2M | $12.2M |
| Net Margin | 2,870.1% | 540.8% | 520.0% | 12,177.0% |
| EPS (Basic) | — | — | — | — |
| EPS (Diluted) | — | — | — | — |
| Shares Outstanding (Basic) | 17.2M | 19.6M | 16.0M | 0 |
| Shares Outstanding (Diluted) | 17.2M | 19.6M | 16.0M | 0 |
| Dividends Per Share | — | — | — | — |